Filing Flows › Comparisons › SMTI vs APT
Sanara MedTech vs Alpha Pro Tech: SMTI and APT compared
Sanara MedTech is the larger company: $28.1M of revenue in its latest quarter (Q2 2026) against $18.7M for Alpha Pro Tech (Q2 2026). Alpha Pro Tech is growing faster (+12% against +9% a year earlier). Alpha Pro Tech is more profitable, with an operating margin of 10.8% against 6.3%.
Where the money goes: SMTI and APT
Sanara MedTech (SMTI) · Q2 2026
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
Alpha Pro Tech (APT) · Q2 2026
Alpha Pro Tech, Q2 2026: revenue $18.7M (+12% year over year), operating margin 10.8%, net earnings $1.8M, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
| Sanara MedTech (SMTI) | Alpha Pro Tech (APT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $28.1M | $18.7M |
| Revenue growth, Y/Y | +9% | +12% |
| Gross margin | — | 37.4% |
| Operating margin | 6.3% | 10.8% |
| Net earnings | −$453K | $1.8M |
| Net margin | -1.6% | 9.8% |
| Operating cash flow | $2.0M | $2.2M |
| Free cash flow | $2.0M | $2.1M |
| Market value | $304M | — |
| P/E | 7.0× | — |
| Analysts’ mean target | $35.00 | — |
Where the revenue comes from
Sanara MedTech
- Soft Tissue Repair Products: $25.2M (90%)
- Bone Fusion Products: $2.9M (10%)
Questions
Which is bigger, Sanara MedTech or Alpha Pro Tech?
Sanara MedTech is the larger company: $28.1M of revenue in its latest quarter (Q2 2026) against $18.7M for Alpha Pro Tech (Q2 2026).
Is Sanara MedTech or Alpha Pro Tech growing faster?
Alpha Pro Tech is growing faster (+12% against +9% a year earlier).
Which is more profitable, Sanara MedTech or Alpha Pro Tech?
Alpha Pro Tech is more profitable, with an operating margin of 10.8% against 6.3%.
More: Sanara MedTech earnings · how Sanara MedTech makes money · Alpha Pro Tech earnings · how Alpha Pro Tech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.